医療におけるメタゲノミクスの世界市場 2020年

• 英文タイトル：Global Metagenomics in Healthcare Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114526 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、医療におけるメタゲノミクスの世界市場を調査対象にし、医療におけるメタゲノミクスの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（サンプル抽出キット、メタゲノミクスキット）、用途別分析（製薬産業、バイオテクノロジー企業、病理学研究所、学術研究所、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Illumina、Thermo Fisher Scientific、QIAGEN、PerkinElmer、Oxford Nanopore Technologies ・企業別売上、市場シェア ・医療におけるメタゲノミクスの地域別市場分析 ・医療におけるメタゲノミクスの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・医療におけるメタゲノミクスのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・医療におけるメタゲノミクスのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・医療におけるメタゲノミクスの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・医療におけるメタゲノミクスの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・医療におけるメタゲノミクスの種類別市場規模2015-2020：サンプル抽出キット、メタゲノミクスキット ・医療におけるメタゲノミクスの用途別市場規模2015-2020：製薬産業、バイオテクノロジー企業、病理学研究所、学術研究所、その他 ・医療におけるメタゲノミクスの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Metagenomics in Healthcare market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Metagenomics in Healthcare market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Metagenomics in Healthcare market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Metagenomics in Healthcare market has been segmented into:
Sample Extraction Kits
Metagenomics Kits

By Application, Metagenomics in Healthcare has been segmented into:
Pharmaceutical Industries
Biotechnology Companies
Pathology Laboratories
Academic and Research Laboratories
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Metagenomics in Healthcare market presented in the report. This section sheds light on the sales growth of different regional and country-level Metagenomics in Healthcare markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Metagenomics in Healthcare market.

The report offers in-depth assessment of the growth and other aspects of the Metagenomics in Healthcare market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Metagenomics in Healthcare Market Share Analysis
Metagenomics in Healthcare competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Metagenomics in Healthcare sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Metagenomics in Healthcare sales, revenue and market share for each player covered in this report.

The major players covered in Metagenomics in Healthcare are:
Illumina
Thermo Fisher Scientific
QIAGEN
PerkinElmer
Oxford Nanopore Technologies

レポート目次

---

1 Metagenomics in Healthcare Market Overview
1.1 Product Overview and Scope of Metagenomics in Healthcare
1.2 Classification of Metagenomics in Healthcare by Type
1.2.1 Global Metagenomics in Healthcare Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Metagenomics in Healthcare Revenue Market Share by Type in 2019
1.2.3 Sample Extraction Kits
1.2.4 Metagenomics Kits
1.3 Global Metagenomics in Healthcare Market by Application
1.3.1 Overview: Global Metagenomics in Healthcare Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical Industries
1.3.3 Biotechnology Companies
1.3.4 Pathology Laboratories
1.3.5 Academic and Research Laboratories
1.3.6 Others
1.4 Global Metagenomics in Healthcare Market by Regions
1.4.1 Global Metagenomics in Healthcare Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Metagenomics in Healthcare (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Metagenomics in Healthcare Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Metagenomics in Healthcare Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Metagenomics in Healthcare Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Metagenomics in Healthcare Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Metagenomics in Healthcare Status and Prospect (2015-2025)
2 Company Profiles
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Illumina SWOT Analysis
2.1.4 Illumina Product and Services
2.1.5 Illumina Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2018-2019)
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Thermo Fisher Scientific SWOT Analysis
2.2.4 Thermo Fisher Scientific Product and Services
2.2.5 Thermo Fisher Scientific Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2018-2019)
2.3 QIAGEN
2.3.1 QIAGEN Details
2.3.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 QIAGEN SWOT Analysis
2.3.4 QIAGEN Product and Services
2.3.5 QIAGEN Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2018-2019)
2.4 PerkinElmer
2.4.1 PerkinElmer Details
2.4.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 PerkinElmer SWOT Analysis
2.4.4 PerkinElmer Product and Services
2.4.5 PerkinElmer Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2018-2019)
2.5 Oxford Nanopore Technologies
2.5.1 Oxford Nanopore Technologies Details
2.5.2 Oxford Nanopore Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Oxford Nanopore Technologies SWOT Analysis
2.5.4 Oxford Nanopore Technologies Product and Services
2.5.5 Oxford Nanopore Technologies Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Metagenomics in Healthcare Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Metagenomics in Healthcare Players Market Share
3.2.2 Top 10 Metagenomics in Healthcare Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Metagenomics in Healthcare Revenue and Market Share by Regions
4.2 North America Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
4.3 Europe Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
4.5 South America Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
5 North America Metagenomics in Healthcare Revenue by Countries
5.1 North America Metagenomics in Healthcare Revenue by Countries (2015-2020)
5.2 USA Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
5.3 Canada Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
5.4 Mexico Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
6 Europe Metagenomics in Healthcare Revenue by Countries
6.1 Europe Metagenomics in Healthcare Revenue by Countries (2015-2020)
6.2 Germany Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
6.3 UK Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
6.4 France Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
6.5 Russia Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
6.6 Italy Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Metagenomics in Healthcare Revenue by Countries
7.1 Asia-Pacific Metagenomics in Healthcare Revenue by Countries (2015-2020)
7.2 China Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
7.3 Japan Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
7.4 Korea Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
7.5 India Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
8 South America Metagenomics in Healthcare Revenue by Countries
8.1 South America Metagenomics in Healthcare Revenue by Countries (2015-2020)
8.2 Brazil Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
8.3 Argentina Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Metagenomics in Healthcare by Countries
9.1 Middle East & Africa Metagenomics in Healthcare Revenue by Countries (2015-2020)
9.2 Saudi Arabia Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
9.3 UAE Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
9.4 Egypt Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
9.5 South Africa Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Metagenomics in Healthcare Revenue and Market Share by Type (2015-2020)
10.2 Global Metagenomics in Healthcare Market Forecast by Type (2019-2024)
10.3 Sample Extraction Kits Revenue Growth Rate (2015-2025)
10.4 Metagenomics Kits Revenue Growth Rate (2015-2025)
11 Global Metagenomics in Healthcare Market Segment by Application
11.1 Global Metagenomics in Healthcare Revenue Market Share by Application (2015-2020)
11.2 Metagenomics in Healthcare Market Forecast by Application (2019-2024)
11.3 Pharmaceutical Industries Revenue Growth (2015-2020)
11.4 Biotechnology Companies Revenue Growth (2015-2020)
11.5 Pathology Laboratories Revenue Growth (2015-2020)
11.6 Academic and Research Laboratories Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Metagenomics in Healthcare Market Size Forecast (2021-2025)
12.1 Global Metagenomics in Healthcare Market Size Forecast (2021-2025)
12.2 Global Metagenomics in Healthcare Market Forecast by Regions (2021-2025)
12.3 North America Metagenomics in Healthcare Revenue Market Forecast (2021-2025)
12.4 Europe Metagenomics in Healthcare Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Metagenomics in Healthcare Revenue Market Forecast (2021-2025)
12.6 South America Metagenomics in Healthcare Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Metagenomics in Healthcare Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Metagenomics in Healthcare Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Metagenomics in Healthcare by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Metagenomics in Healthcare Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Metagenomics in Healthcare Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Illumina Corporate Information, Location and Competitors
Table 6. Illumina Metagenomics in Healthcare Major Business
Table 7. Illumina Metagenomics in Healthcare Total Revenue (USD Million) (2017-2018)
Table 8. Illumina SWOT Analysis
Table 9. Illumina Metagenomics in Healthcare Product and Solutions
Table 10. Illumina Metagenomics in Healthcare Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 12. Thermo Fisher Scientific Metagenomics in Healthcare Major Business
Table 13. Thermo Fisher Scientific Metagenomics in Healthcare Total Revenue (USD Million) (2018-2019)
Table 14. Thermo Fisher Scientific SWOT Analysis
Table 15. Thermo Fisher Scientific Metagenomics in Healthcare Product and Solutions
Table 16. Thermo Fisher Scientific Metagenomics in Healthcare Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. QIAGEN Corporate Information, Location and Competitors
Table 18. QIAGEN Metagenomics in Healthcare Major Business
Table 19. QIAGEN Metagenomics in Healthcare Total Revenue (USD Million) (2017-2018)
Table 20. QIAGEN SWOT Analysis
Table 21. QIAGEN Metagenomics in Healthcare Product and Solutions
Table 22. QIAGEN Metagenomics in Healthcare Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. PerkinElmer Corporate Information, Location and Competitors
Table 24. PerkinElmer Metagenomics in Healthcare Major Business
Table 25. PerkinElmer Metagenomics in Healthcare Total Revenue (USD Million) (2017-2018)
Table 26. PerkinElmer SWOT Analysis
Table 27. PerkinElmer Metagenomics in Healthcare Product and Solutions
Table 28. PerkinElmer Metagenomics in Healthcare Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Oxford Nanopore Technologies Corporate Information, Location and Competitors
Table 30. Oxford Nanopore Technologies Metagenomics in Healthcare Major Business
Table 31. Oxford Nanopore Technologies Metagenomics in Healthcare Total Revenue (USD Million) (2017-2018)
Table 32. Oxford Nanopore Technologies SWOT Analysis
Table 33. Oxford Nanopore Technologies Metagenomics in Healthcare Product and Solutions
Table 34. Oxford Nanopore Technologies Metagenomics in Healthcare Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Global Metagenomics in Healthcare Revenue (Million USD) by Players (2015-2020)
Table 36. Global Metagenomics in Healthcare Revenue Share by Players (2015-2020)
Table 37. Global Metagenomics in Healthcare Revenue (Million USD) by Regions (2015-2020)
Table 38. Global Metagenomics in Healthcare Revenue Market Share by Regions (2015-2020)
Table 39. North America Metagenomics in Healthcare Revenue by Countries (2015-2020)
Table 40. North America Metagenomics in Healthcare Revenue Market Share by Countries (2015-2020)
Table 41. Europe Metagenomics in Healthcare Revenue (Million USD) by Countries (2015-2020)
Table 42. Asia-Pacific Metagenomics in Healthcare Revenue (Million USD) by Countries (2015-2020)
Table 43. South America Metagenomics in Healthcare Revenue by Countries (2015-2020)
Table 44. South America Metagenomics in Healthcare Revenue Market Share by Countries (2015-2020)
Table 45. Middle East and Africa Metagenomics in Healthcare Revenue (Million USD) by Countries (2015-2020)
Table 46. Middle East and Africa Metagenomics in Healthcare Revenue Market Share by Countries (2015-2020)
Table 47. Global Metagenomics in Healthcare Revenue (Million USD) by Type (2015-2020)
Table 48. Global Metagenomics in Healthcare Revenue Share by Type (2015-2020)
Table 49. Global Metagenomics in Healthcare Revenue Forecast by Type (2021-2025)
Table 50. Global Metagenomics in Healthcare Revenue by Application (2015-2020)
Table 51. Global Metagenomics in Healthcare Revenue Share by Application (2015-2020)
Table 52. Global Metagenomics in Healthcare Revenue Forecast by Application (2021-2025)
Table 53. Global Metagenomics in Healthcare Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Metagenomics in Healthcare Picture
Figure 2. Global Metagenomics in Healthcare Revenue Market Share by Type in 2019
Figure 3. Sample Extraction Kits Picture
Figure 4. Metagenomics Kits Picture
Figure 5. Metagenomics in Healthcare Revenue Market Share by Application in 2019
Figure 6. Pharmaceutical Industries Picture
Figure 7. Biotechnology Companies Picture
Figure 8. Pathology Laboratories Picture
Figure 9. Academic and Research Laboratories Picture
Figure 10. Others Picture
Figure 11. Global Metagenomics in Healthcare Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Metagenomics in Healthcare Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Metagenomics in Healthcare Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Metagenomics in Healthcare Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Metagenomics in Healthcare Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Metagenomics in Healthcare Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Metagenomics in Healthcare Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Metagenomics in Healthcare Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Metagenomics in Healthcare Revenue Market Share in 2019
Figure 20. Global Top 10 Players Metagenomics in Healthcare Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Metagenomics in Healthcare Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Metagenomics in Healthcare Revenue Market Share by Regions (2015-2020)
Figure 24. Global Metagenomics in Healthcare Revenue Market Share by Regions in 2018
Figure 25. North America Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 26. Europe Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 28. South America Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 30. North America Metagenomics in Healthcare Revenue Market Share by Countries (2015-2020)
Figure 31. North America Metagenomics in Healthcare Revenue Market Share by Countries in 2019
Figure 32. USA Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 33. Canada Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 35. Europe Metagenomics in Healthcare Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Metagenomics in Healthcare Revenue Market Share by Countries in 2019
Figure 37. Germany Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 38. UK Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 39. France Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 40. Russia Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 41. Italy Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Metagenomics in Healthcare Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Metagenomics in Healthcare Revenue Market Share by Countries in 2019
Figure 44. China Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 45. Japan Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 46. Korea Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 47. India Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 49. South America Metagenomics in Healthcare Revenue Market Share by Countries (2015-2020)
Figure 50. South America Metagenomics in Healthcare Revenue Market Share by Countries in 2019
Figure 51. Brazil Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Metagenomics in Healthcare Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Metagenomics in Healthcare Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 56. UAE Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Metagenomics in Healthcare Revenue and Growth Rate (2015-2020)
Figure 59. Global Metagenomics in Healthcare Revenue Share by Type (2015-2020)
Figure 60. Global Metagenomics in Healthcare Revenue Share by Type in 2019
Figure 61. Global Metagenomics in Healthcare Market Share Forecast by Type (2021-2025)
Figure 62. Global Sample Extraction Kits Revenue Growth Rate (2015-2020)
Figure 63. Global Metagenomics Kits Revenue Growth Rate (2015-2020)
Figure 64. Global Metagenomics in Healthcare Revenue Share by Application (2015-2020)
Figure 65. Global Metagenomics in Healthcare Revenue Share by Application in 2019
Figure 66. Global Metagenomics in Healthcare Market Share Forecast by Application (2021-2025)
Figure 67. Global Pharmaceutical Industries Revenue Growth Rate (2015-2020)
Figure 68. Global Biotechnology Companies Revenue Growth Rate (2015-2020)
Figure 69. Global Pathology Laboratories Revenue Growth Rate (2015-2020)
Figure 70. Global Academic and Research Laboratories Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Metagenomics in Healthcare Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Metagenomics in Healthcare Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Metagenomics in Healthcare Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Metagenomics in Healthcare Revenue Market Forecast (2021-2025)
Figure 76. Europe Metagenomics in Healthcare Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Metagenomics in Healthcare Revenue Market Forecast (2021-2025)
Figure 78. South America Metagenomics in Healthcare Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Metagenomics in Healthcare Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---